Efficacy and Safety of Bevacizumab with Capecitabine and Cisplatin in Patients with Advanced Gastric Cancer
Submitted by web@researchtop... on Mon, 08/02/2010 - 13:16
Cetuximab with Chemotherapy as Treatment for Stage III Colon or Metastatic Colorectal Cancer
Submitted by web@researchtop... on Mon, 08/02/2010 - 12:48
Use of Bevacizumab in the Neoadjuvant Setting for Patients with Locally Advanced Rectal Cancer
Submitted by web@researchtop... on Mon, 08/02/2010 - 12:40
Use of Bevacizumab in the Maintenance Setting for Patients with Metastatic Colorectal Cancer (mCRC)
Submitted by web@researchtop... on Mon, 08/02/2010 - 12:31
Efficacy and Safety of FOLFIRINOX in Patients with Metastatic Pancreatic Cancer
Submitted by web@researchtop... on Mon, 08/02/2010 - 12:15
5-Minute Journal Club — ASCO 2010 Presentations
Submitted by web@researchtop... on Mon, 08/02/2010 - 11:30
Carboplatin and Paclitaxel as Therapy for Elderly Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Submitted by web@researchtop... on Thu, 07/29/2010 - 14:08
Year in Review – Gastrointestinal Cancers: 2009-2010
Submitted by web@researchtop... on Thu, 07/29/2010 - 11:05
Year in Review – Gastrointestinal Cancers: 2009-2010 |
|---|
Effect of Early Palliative Care on End-of-Life Care Outcomes among Patients with Metastatic NSCLC
Submitted by web@researchtop... on Tue, 07/27/2010 - 18:02
NCIC CTG BR.19: Gefitinib Therapy for Patients with Completely Resected Non-Small Cell Lung Cancer (NSCLC)
Submitted by web@researchtop... on Tue, 07/27/2010 - 17:59
First-Line Erlotinib with or without Chemotherapy for Never or Light Smokers with Advanced Non-Small Cell Lung Cancer (NSCLC)
Submitted by web@researchtop... on Tue, 07/27/2010 - 17:56
First-in-Human Study of the Oral ALK Inhibitor Crizotinib for Patients with ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
Submitted by web@researchtop... on Tue, 07/27/2010 - 17:52
5-Minute Journal Club — ASCO 2010 Presentations
Submitted by web@researchtop... on Tue, 07/27/2010 - 16:46
Safety and Efficacy of Bosutinib in Chronic-Phase Chronic Myeloid Leukemia (CML-CP) After Resistance or Intolerance to Imatinib
Submitted by web@researchtop... on Fri, 07/23/2010 - 10:16
Update of the ENESTnd Study: Comparison of Nilotinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)
Submitted by web@researchtop... on Fri, 07/23/2010 - 10:14